Protagenic Therapeutics, Inc.new PTIX
OTC PTIX
$0.45 -0.02 (-4.66%)
As of: Nov 16, 2026 · 3:48 PM EST

Protagenic Therapeutics, Inc.new (PTIX) Equity Income (2009 - 2011)

Updated

Protagenic Therapeutics, Inc.new (PTIX) posted Equity Income of -$9,000 for fiscal Q3 2013 (quarter ended Sep 30, 2011).

Analysis

Protagenic Therapeutics, Inc.new (PTIX) Equity Income (2009 - 2011) Analysis & Trends

For the trailing twelve months through Sep 30, 2011, Equity Income at Protagenic Therapeutics, Inc.new was $95,000.

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Equity Income (Qtr)
1 Eli Lilly 1,276.89 Bn 1,250.50 Bn 20.46 Bn -
2 Johnson & Johnson 681.31 Bn 601.18 Bn 17.30 Bn -
3 AbbVie 520.63 Bn 488.64 Bn 13.12 Bn -
4 Merck 357.22 Bn 320.16 Bn 13.19 Bn -
5 Novartis Ag 310.90 Bn 284.14 Bn - -
6 Astrazeneca 285.12 Bn 258.77 Bn 13.26 Bn -19.00 Mn
7 Amgen 250.23 Bn 201.89 Bn 7.58 Bn -
8 Gilead Sciences 207.56 Bn 182.67 Bn 6.73 Bn -
9 Pfizer 164.42 Bn 111.77 Bn 12.56 Bn -
10 Protagenic Therapeutics, Inc.new 850,797.76 -4.70 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2011 -9,000.00
Jun 30, 2011 67,000.00
Sep 30, 2010 -13,000.00
Jun 30, 2010 50,000.00
Dec 31, 2009 -173,000.00
Sep 30, 2009 62,000.00
Jun 30, 2009 -33,000.00
Mar 31, 2009 85,000.00
API Access

Protagenic Therapeutics, Inc.new Equity Income API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=equity-income&ticker=PTIX&period=max&api_key=YOUR_API_KEY